1. P05.05.B A new IDH-wildtype glioma subtype characterized by highly diffuse growth pattern, distinct epigenetic profile and relatively favorable prognosis. (5th September 2022) Authors: Münch, A; Teichmann, D; Kuzman, P; Spille, D; Perez, E; May, S; Mueller, W; Kombos, T; Nazari-Dehkordi, S; Onken, J; Vajkoczy, P; Ntoulias, G; Paulus, W; Heppner, F; Koch, A; Capper, D; Kaul, D; Thomas, C; Schweizer, L Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P11.15.B First multicentric real-life experience with the combination of lomustine and temozolomide in newly diagnosedMGMT promoter methylatedIDH wildtype glioblastoma. (5th September 2022) Authors: Lazaridis, L; Schmidt, T; Agkatsev, S; Blau, T; Spille, D; Heider, S; Schulz, T; Bumes, E; Oster, C; Feldheim, J; Stummer, W; Kessler, A; Seidel, C; Hau, P; Sure, U; Keyvani, K; Herrlinger, U; Kleinschnitz, C; Stuschke, M; Herrmann, K Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗